Prevention of CRS involves strategies to identify high-risk patients and modify treatment protocols accordingly. Preemptive administration of corticosteroids or IL-6 inhibitors before initiating CAR T-cell therapy can reduce the incidence and severity of CRS. Continuous monitoring and early intervention at the first sign of symptoms are crucial in preventing severe complications.
